Calamos Advisors’s Vera Therapeutics VERA Stock Holding History

Calamos Advisors’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13,146	Closed	-$529K	–	1274
2026 Q1	$529K	Buy	+13,146	New	+$566K	﹤0.01%	900

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Calamos Advisors's VERA Position: Q2 2026 in Review

Calamos Advisors sold out of Vera Therapeutics (VERA) in Q2 2026, closing a stake of 13,146 shares — an estimated $529K sold.

Calamos Advisors first reported a position in VERA in Q1 2026 and held it in 1 quarter. The position peaked at $529K in Q1 2026. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Calamos Advisors reported no remaining Vera Therapeutics position as of Q2 2026 after selling out during the quarter.
Calamos Advisors sold 13,146 Vera Therapeutics shares in Q2 2026, an estimated $529K.
Calamos Advisors first reported a position in Vera Therapeutics in Q1 2026 and held it in 1 quarter.
Calamos Advisors's Vera Therapeutics position peaked at $529K in Q1 2026.
220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.